Publicaciones en las que colabora con Ana Belén Sanz Bartolomé (13)

2014

  1. Unilateral ureteral obstruction: Beyond obstruction

    International Urology and Nephrology, Vol. 46, Núm. 4, pp. 765-776

2012

  1. HSP27/HSPB1 as an adaptive podocyte antiapoptotic protein activated by high glucose and angiotensin II

    Laboratory Investigation, Vol. 92, Núm. 1, pp. 32-45

  2. TWEAK (tumor necrosis factor-like weak inducer of apoptosis) activates CXCL16 expression during renal tubulointerstitial inflammation

    Kidney International, Vol. 81, Núm. 11, pp. 1098-1107

2010

  1. TNF superfamily: A growing saga of kidney injury modulators

    Mediators of Inflammation, Vol. 2010

2009

  1. La transcriptómica ilustra nuevas vías letales en la nefropatía diabética

    Nefrologia, Vol. 29, Núm. 1, pp. 13-19

  2. Myocardial fibrosis and apoptosis, but not inflammation, are present in long-term experimental diabetes

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 297, Núm. 6

  3. Taming apoptosis in peritoneal dialysis

    Peritoneal Dialysis International

2008

  1. Apoptosis: From advances in PD to therapeutic targets in DM

    Nefrologia

  2. TWEAK, el facilitador del daño renal agudo

    Nefrologia

  3. TWEAKing renal injury

    Frontiers in Bioscience, Vol. 13, Núm. 2, pp. 580-589

2006

  1. 3,4-DGE is important for side effects in peritoneal dialysis what about its role in diabetes

    Current Medicinal Chemistry, Vol. 13, Núm. 22, pp. 2695-2702

  2. Modulation of renal tubular cell survival: Where is the evidence?

    Current Medicinal Chemistry, Vol. 13, Núm. 4, pp. 449-454

  3. Peritoneal defence - Lessons learned which apply to diabetes complications

    Nephrology Dialysis Transplantation, Vol. 21, Núm. SUPPL. 2